# FDA Inspection 1190752 - Octapharma Plasma Inc - November 10, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/18bed8d5-cd94-4d82-9127-27ba2bd1b826
Source feed: FDA_Inspections

> FDA Inspection 1190752 for Octapharma Plasma Inc on November 10, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1190752
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2022-11-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1190752 - 2022-11-10](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/6cee4283-cbfa-4e90-b07c-89ac800b3814)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/f4be7ccf-422b-4a61-b79f-6f6f9cb16378

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d